L
Lan Zeng
Researcher at University of Wisconsin-Madison
Publications - 7
Citations - 1702
Lan Zeng is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Chest radiograph & Randomized controlled trial. The author has an hindex of 6, co-authored 7 publications receiving 1656 citations.
Papers
More filters
Journal ArticleDOI
Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth
Philip M. Farrell,Michael R. Kosorok,Michael J. Rock,Anita Laxova,Lan Zeng,HuiChuan J. Lai,Gary Hoffman,Ronald H. Laessig,Mark Splaingard +8 more
TL;DR: The Wisconsin CF Neonatal Screening Project as discussed by the authors was designed as a randomized clinical trial to assess the benefits and risks of early diagnosis through screening, and the validity of the randomization method assessed by comparing 16 demographic variables.
Journal ArticleDOI
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition
Michael R. Kosorok,Lan Zeng,Susan E. H. West,Michael J. Rock,Mark Splaingard,Anita Laxova,Christopher G. Green,Jannette Collins,Philip M. Farrell +8 more
TL;DR: The data show that Pa acquisition is associated with declining pulmonary status in children with CF, and that this effect is probably gradual rather than precipitous.
Journal ArticleDOI
Relationship between adolescent–parental communication and initiation of first intercourse by adolescents
TL;DR: Teenagers who perceive that they have a better level of communication with their parents are less likely to engage in sexual intercourse.
Journal ArticleDOI
Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
Susan E. H. West,Lan Zeng,Bee Leng Lee,Michael R. Kosorok,Anita Laxova,Michael J. Rock,Mark J. Splaingard,Philip M. Farrell +7 more
TL;DR: In CF patients diagnosed through neonatal screening, P aeruginosa pulmonary infections occurred 6 to 12 months before the organism was isolated from respiratory secretions, and treatment with long-term, non-Pseudomonas oral antibiotics and integration of CF infants with older, chronically infected patients were associated with a significantly increased risk of P aerugenosa pulmonary infection.